Details for New Drug Application (NDA): 019194
✉ Email this page to a colleague
The generic ingredient in SYPRINE is trientine hydrochloride. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
Summary for 019194
Tradename: | SYPRINE |
Applicant: | Bausch |
Ingredient: | trientine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 019194
Mechanism of Action | Metal Chelating Activity |
Medical Subject Heading (MeSH) Categories for 019194
Suppliers and Packaging for NDA: 019194
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SYPRINE | trientine hydrochloride | CAPSULE;ORAL | 019194 | NDA | Bausch Health US LLC | 0187-2120 | 0187-2120-10 | 1 BOTTLE in 1 CARTON (0187-2120-10) / 100 CAPSULE in 1 BOTTLE |
SYPRINE | trientine hydrochloride | CAPSULE;ORAL | 019194 | NDA AUTHORIZED GENERIC | Oceanside Pharmaceutials | 68682-212 | 68682-212-10 | 1 BOTTLE in 1 CARTON (68682-212-10) / 100 CAPSULE in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Nov 8, 1985 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription